Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up.
Michael CarstensJessy TrujilloYanury DolmusCarlos RiveraSantos CalderwoodJudith LejarzaCarlos LópezKenneth Bertram
Published in: Cytotherapy (2024)
It is not possible to distinguish between naturally occurring improvement or improvement caused by SVF treatment in this small, uncontrolled study. However, the results support further study of autologous AD SVF as a treatment for long COVID.